Nation

Covaxin gets emergency use approval for children aged 2-18 years

Name: Covaxin gets emergency use approval for children aged 2-18 years
Uploaded: 2021-10-14T10:26:00Z
Description: Subject Expert Committee ( SEC) has recommended granting an emergency use authorisation to Bharat Biotech's #Covaxin for children aged between 2-18. The SEC has submitted its recommendation to the Drugs Controller General of India (DCGI) for final approval. Bharat Biotech had last week submitted Phase 2/3 clinical trials data of children's trials to the DCGI.

Online Desk

Updated:14th Oct, 2021 at 3:56 PM

Follow The New Indian Express channel on WhatsApp

Download the TNIE app to stay with us and follow the latest